I am a Research Professor at Yonsei University, Korea, where I work at the forefront of applying artificial intelligence (AI), machine learning (ML), and Digital Twin technologies to revolutionize biopharmaceutical manufacturing. My primary research is focused on the development of mRNA and siRNA-based lipid nanoparticle (LNP) vaccines, biopharmaceutical manufacturing processes, lyophilization, formulation stabilization, and targeted drug delivery approaches to the ocular system and the brain. I hold a PhD in Pharmaceutics with High Distinction (GPA 4.46/4.5) from Dongguk University, where I also previously served as a Research Professor. Throughout my academic career, I have built a strong publication record featuring 31+ scientific papers (primarily in SCIE Q1 journals), three books, and five book chapters. I have also co-developed a patented technology in collaboration with ST Pharm focused on the stabilization of freeze-dried siRNA/mRNA LNP formulations using sucrose and cyclodextrin. In addition to my research, I am deeply committed to editorial leadership and peer review. I currently serve as an Associate Editor for IEEE Transactions on NanoBioscience and Pharmaceutical Science and Technology, and as an Editorial Board Member for Nature Portfolio's Scientific Reports and MDPI Pharmaceutics. Key Interests & Mission: I am passionate about implementing advanced digital tools—such as AI agents, predictive modeling, Quality by Design (QbD), Design of Experiments (DoE).